Mitotic and meiotic midbody remnants: Divergent architectures with distinct clinical applications.
- 1Department of Genetics, Rutgers, The State University of NJ, Piscataway, NJ 08854, USA. Electronic address: [email protected].
- 2Laboratory of Genetics, UW-Madison, Madison, WI 53706, USA. Electronic address: [email protected].
Abstract
Midbody remnants (MBRs), once considered inert cytokinetic debris, are now recognized as architecturally specialized, translationally active organelles whose functions reflect the mode of cell division. This review compares MBR biology in symmetric somatic mitosis and asymmetric oocyte meiosis. In somatic cells, MBRs can be retained or secreted as large extracellular vesicles that carry midbody proteins, RNAs, and translation machinery; their enrichment in stem and cancer cells implicates them in cell-state regulation and identifies them as promising, though unvalidated, substrates for liquid-biopsy biomarkers and therapeutic targeting. In oocytes, meiotic midbodies form a distinctive ring-cap architecture that concentrates local translation and restricts maternal products to the egg, thereby supporting developmental competence. Together, these studies establish division mode as a key determinant of midbody architecture, cargo, fate, and translational potential, linking cytokinesis to cancer biology and reproductive medicine.
Related
- Distinct extracellular architectures shape mechanical persistence in GPVI and CLEC-2 receptor assemblies
- Flow Cytometry and AI-Driven Biomarker Discovery in Acute Kidney Injury: From Mechanistic Insights to Translation Applications in Clinical and Austere Environments
- Somatostatin Receptor Expression and Theranostic Applications Across Non-Neuroendocrine Tumors: A Molecular-to-Clinical Review
- Saturation mutagenesis enables RAD51D clinical variant interpretation and identifies distinct biochemical functions
- Ubiquitin-Derived Diglycine Remnants as Chemical Handles for Chemoenzymatic Proteomics
BibTeX
@article{schindler2026mitotic,
title = {{Mitotic and meiotic midbody remnants: Divergent architectures with distinct clinical applications.}},
author = {Karen Schindler and Ahna R Skop},
journal = {Cell genomics},
year = {2026},
month = oct,
doi = {10.1016/j.xgen.2026.101386},
url = {https://europepmc.org/article/MED/42874568},
note = {CC BY},
}
RIS
TY - JOUR
TI - Mitotic and meiotic midbody remnants: Divergent architectures with distinct clinical applications.
AU - Karen Schindler
AU - Ahna R Skop
PY - 2026
DA - 2026/10/01
JO - Cell genomics
DO - 10.1016/j.xgen.2026.101386
UR - https://europepmc.org/article/MED/42874568
AB - Midbody remnants (MBRs), once considered inert cytokinetic debris, are now recognized as architecturally specialized, translationally active organelles whose functions reflect the mode of cell division. This review compares MBR biology in symmetric somatic mitosis and asymmetric oocyte meiosis. In somatic cells, MBRs can be retained or secreted as large extracellular vesicles that carry midbody proteins, RNAs, and translation machinery; their enrichment in stem and cancer cells implicates them in cell-state regulation and identifies them as promising, though unvalidated, substrates for liquid-biopsy biomarkers and therapeutic targeting. In oocytes, meiotic midbodies form a distinctive ring-cap architecture that concentrates local translation and restricts maternal products to the egg, thereby supporting developmental competence. Together, these studies establish division mode as a key determinant of midbody architecture, cargo, fate, and translational potential, linking cytokinesis to cancer biology and reproductive medicine.
SN - 2666-979X
ER -